QIAGEN partners with sequencing provider
QIAGEN N.V. announced that it has expanded its relationship with BG to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services.
Under the reseller agreement, BGI customers will receive sequencing data generated from their samples through Ingenuity Variant Analysis‘ secure, cloud-based environment and gain access to its leading comprehensive gene variant data and genomic interpretation applications
“We are very pleased to expand QIAGEN’s relationship with BGI, the global leader in sequencing services. Integrating Ingenuity Variant Analysis into BGI’s highly reliable sequencing services will enable clients to accelerate workflows. They’ll be able to transform large quantities of genomic data into valuable molecular insights for research or clinical applications,” said Laura Furmanski, Head of QIAGEN’s Bioinformatics Business Area. “Bioinformatics solutions from QIAGEN are growing rapidly as scientists and healthcare professionals increasingly use genomic information to guide research and provide precise diagnosis for medical decision-making. We are committed to working with leading organizations such as BGI to make these improvements in life possible.”
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Making cars and airplanes cheaper, safer and more efficient - DFG funds 2 major instruments to test components made of fiber-reinforced composites
Enterome and Nestlé Health Science launch new diagnostics company
New wheat diversity discovery could provide an urgently-needed solution to global food security - Newly-discovered diversity in the wheat genome could offer vital new opportunities to improve and ‘climate-proof’ one of the world’s most important staple crops
Hidden properties of solids
Raman Microspectroscopy for Microbiology - Methodology can provide new insights into a variety of key topics in microbiology
Norwegian Team Completes Cod Genome
Biotage AB and McMaster University sign two year extension to Molecular Imaging Development Agreement
Malvern Panalytical agrees to acquire Micromeritics, to become world leaders in materials characterization
Aignostics Raises €14m Series A to Advance AI-powered Pathology - Spin-off from Charité developing sophisticated AI models to improve understanding, diagnosis and treatment of complex diseases
New Clues to Mechanism for "Colossal Resistance" Effects - Understanding could lead to lower-power, increased-memory data-storage devices
